Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients with multiple weight-related health conditions who fall below the current NHS eligibility threshold for tirzepatide, also called Mounjaro, are not excluded from other forms of treatment.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the NHS on whether new medicines represent a clinically and cost-effective use of resources. NICE estimated that approximately 3.4 million people are eligible for tirzepatide to treat obesity.

The National Health Service is currently rolling out tirzepatide in primary care, prioritising those with the highest clinical need first. NHS England has worked with clinical experts, integrated care boards, patient and public representatives, healthcare professionals, charities and royal colleges on its prioritisation approach, which it set out in its interim commissioning guidance. This is available at the following link:

https://www.england.nhs.uk/publication/interim-commissioning-guidance-implementation-of-the-nice-technology-appraisal-ta1026-and-the-nice-funding-variation-for-tirzepatide-mounjaro-for-the-management-of-obesity/

As part of the rollout plans, the NHS will look at different service models, including digital and community options and will speed up roll out if possible. Progress on the NHS rollout of tirzepatide will be reviewed by NICE in three years.

For those not currently eligible for tirzepatide, there are a variety of weight management services provided by the NHS and local government. These range from multi-component behavioural programmes to specialist services for those living with severe obesity and associated co-morbidities. All weight management services will have some form of eligibility criteria to ensure that they are targeted at those most likely to benefit. For example, the NHS Digital Weight Management Programme is a behavioural programme primarily aimed at adults living with obesity who also have type 2 diabetes and/or hypertension.